Should baricitinib dosage be reduced when adequate response is achieved?Featuring James Del Rosso, DO | Clinical Advisor | Adjunct Clinical Professor, DermatologyTouro University NevadaHenderson, NV | Published October 01, 2023View video transcriptLoading...Related MediaPowered by Polaris TM